Understanding Proliferative Diabetic Retinopathy
Proliferative diabetic retinopathy, often referred to as PDR, is the most advanced and serious stage of diabetic retinopathy. This condition develops when diabetes causes progressive damage to the tiny blood vessels that nourish the retina, which is the light-sensitive tissue lining the back of the eye. In PDR, the retina becomes so deprived of adequate blood flow that it triggers the growth of new, abnormal blood vessels on the surface of the retina and along the optic nerve. This process of new vessel growth is called neovascularization.
Diabetic retinopathy affects 7.7 million Americans and is the leading cause of blindness among working-age adults (National Eye Institute, 2023). Understanding this condition is an essential first step in protecting your sight and making informed decisions about your eye care. At Washington Eye Institute, our goal is to help patients understand PDR so they can take an active role in preserving their vision.
Diabetic retinopathy progresses through distinct stages. It begins as non-proliferative diabetic retinopathy, or NPDR, in which the existing blood vessels in the retina weaken and develop small bulges called microaneurysms. These damaged vessels may leak fluid and blood into the retinal tissue, causing swelling. Over time, the damage worsens, and larger areas of the retina lose their blood supply.
When enough retinal blood vessels become blocked or closed off, the retina is left without sufficient oxygen and nutrients. In response, the body attempts to compensate by growing new blood vessels to restore circulation. While this might sound like a helpful process, these newly formed vessels are structurally fragile and abnormal. They grow along the retinal surface and into the vitreous, the clear gel that fills the center of the eye. Because they are so delicate, these vessels bleed easily, leak fluid, and can form scar tissue that pulls on the retina.
The key distinction between non-proliferative and proliferative diabetic retinopathy lies in the presence of neovascularization. In NPDR, damage occurs within the existing blood vessels, but no new abnormal vessels grow. The retina may show microaneurysms, hemorrhages, and areas of swelling, but the condition remains contained within the original vascular network.
PDR represents a significant escalation in severity. The growth of fragile new vessels introduces risks that do not exist in NPDR, including vitreous hemorrhage and tractional retinal detachment. These complications can lead to sudden and severe vision loss. For this reason, the transition from NPDR to PDR marks a critical turning point that requires close monitoring and timely intervention.
Determining If You Need Treatment
One of the challenges of proliferative diabetic retinopathy is that it may not produce noticeable symptoms in its early stages. Some patients experience no changes in vision until a serious complication occurs, such as a vitreous hemorrhage. When symptoms do appear, they may include the following indicators.
- Sudden appearance of dark spots or floaters drifting across your field of vision
- Blurred or fluctuating vision that changes from day to day
- Dark or empty areas in your central or peripheral vision
- Difficulty seeing at night or in low-light conditions
- A sudden, significant decrease in vision in one or both eyes
If you notice any of these changes, it is important to contact your eye care provider promptly. A sudden shower of floaters or a dark curtain appearing across your vision may indicate a vitreous hemorrhage or retinal detachment, both of which require urgent evaluation.
Several factors increase the likelihood that diabetic retinopathy will progress to the proliferative stage. Understanding these risk factors can help you and your care team stay vigilant. Common risk factors include the following.
- Having diabetes for an extended period, particularly ten years or longer
- Poorly controlled blood sugar levels over time
- High blood pressure that is not well managed
- Elevated cholesterol levels
- Pregnancy in women with pre-existing diabetes
- Tobacco use, which affects blood vessel health
People with type one diabetes have a particularly high likelihood of developing PDR over the course of their lifetime, though the condition also affects many people with type two diabetes. The longer you have had diabetes, the greater the importance of regular eye examinations.
Early detection through comprehensive eye exams can prevent up to 95% of diabetes-related vision loss (National Eye Institute, 2023). All individuals with diabetes should have a dilated eye examination at least once per year, even if their vision seems normal. If your eye care provider has identified non-proliferative diabetic retinopathy, you may need more frequent monitoring to detect any progression to PDR as early as possible.
You should seek immediate evaluation if you experience a sudden increase in floaters, flashes of light, a shadow or curtain effect in your vision, or any rapid decline in visual clarity. These symptoms could signal a vitreous hemorrhage or retinal detachment, and timely treatment can be critical for preserving vision.
How Proliferative Diabetic Retinopathy Is Treated
Treatment for proliferative diabetic retinopathy aims to stop or slow the growth of abnormal blood vessels, reduce the risk of vitreous hemorrhage and retinal detachment, and preserve as much functional vision as possible. While treatment cannot restore vision that has been lost, it can be highly effective at preventing further damage when delivered in a timely manner.
The approach to treatment depends on the severity of the condition, the specific complications present, and the overall health of each patient. In many cases, a combination of therapies provides the most effective results. Your retina specialist will work with you to develop a treatment plan tailored to your individual situation.
The abnormal blood vessels that characterize PDR grow in response to a protein called vascular endothelial growth factor, or VEGF. When the retina is starved of oxygen, it produces elevated levels of VEGF, which signals the body to create new blood vessels. Modern treatments for PDR work by interrupting this process through different mechanisms.
Some therapies block the VEGF protein directly, preventing it from stimulating new vessel growth. Other approaches use focused light energy to seal off or destroy abnormal vessels and reduce the retina's demand for oxygen. In advanced cases, surgical intervention may be needed to remove blood or scar tissue from inside the eye and repair damage to the retina itself.
Medical treatment of the eye is only one part of managing proliferative diabetic retinopathy. Controlling blood sugar levels is a fundamental component of slowing disease progression and improving treatment outcomes. Patients who maintain their hemoglobin A1c at levels recommended by their primary care provider or endocrinologist tend to have better long-term results.
Managing blood pressure, cholesterol, and other systemic health factors also contributes to protecting the blood vessels throughout the body, including those in the retina. A coordinated approach between your eye care team and your diabetes management team provides the strongest foundation for protecting your vision over time.
Types of Treatment for Proliferative Diabetic Retinopathy
Anti-VEGF injections have become a cornerstone of treatment for proliferative diabetic retinopathy. These medications are delivered directly into the vitreous cavity of the eye through a very fine needle. Once inside the eye, anti-VEGF medications bind to the VEGF protein and block its ability to stimulate abnormal blood vessel growth.
The effects of anti-VEGF therapy include the following benefits.
- Causing existing abnormal blood vessels to regress and shrink
- Reducing leakage from damaged blood vessels
- Decreasing swelling in the retina
- Lowering the risk of vitreous hemorrhage
- Helping stabilize or improve visual acuity in many patients
Anti-VEGF injections are typically administered as a series of treatments over time. The initial phase often involves injections given at regular intervals, followed by ongoing monitoring to determine whether additional treatments are needed. Many patients require continued injections over months or years to maintain the benefits of therapy.
Panretinal photocoagulation, commonly known as PRP, is a well-established laser treatment for proliferative diabetic retinopathy. During PRP, a specially focused laser is used to create hundreds to thousands of tiny burns across the peripheral retina, deliberately treating areas that have lost their blood supply.
This may seem counterintuitive, but the treatment works by reducing the total amount of retinal tissue that requires oxygen. When the oxygen-starved peripheral retina is treated, it produces less VEGF, which in turn reduces the stimulus for abnormal vessel growth. PRP has been used for decades and has a strong track record of reducing the risk of severe vision loss from PDR.
PRP is typically performed over one to three treatment sessions. Some patients experience mild discomfort during the procedure, and temporary changes in peripheral vision or night vision may occur as the treated areas heal. Your retina specialist at Washington Eye Institute will discuss what to expect based on the extent of treatment needed.
Vitrectomy is a surgical procedure reserved for more advanced cases of proliferative diabetic retinopathy, particularly when complications such as vitreous hemorrhage or tractional retinal detachment have occurred. During a vitrectomy, the surgeon makes tiny incisions in the wall of the eye and uses specialized microsurgical instruments to remove the vitreous gel, along with any blood, scar tissue, or membranes that are present.
Vitrectomy may be recommended in the following situations.
- A vitreous hemorrhage that does not clear on its own within a reasonable timeframe
- Tractional retinal detachment that threatens or involves the central vision area
- A combination of tractional and rhegmatogenous retinal detachment
- Dense scar tissue formation that is pulling on the retinal surface
After the vitreous is removed, the surgeon may use laser treatment inside the eye, inject gas or silicone oil to hold the retina in place, or perform other repairs as needed. The vitreous cavity gradually fills with fluid that the eye produces naturally. Recovery from vitrectomy varies depending on the complexity of the case, and your surgeon will provide detailed instructions for the postoperative period.
What to Expect During Treatment
Before any treatment for proliferative diabetic retinopathy, you will undergo a comprehensive eye examination that includes dilation of your pupils and specialized imaging of the retina. Common diagnostic tests include optical coherence tomography, known as OCT, and fluorescein angiography, which uses a special dye to photograph the blood vessels in the retina.
To prepare for your treatment appointment, you should plan for the following steps.
- Arrange for someone to drive you home, as your vision may be blurred after treatment
- Inform your care team of all medications you are currently taking
- Discuss any blood-thinning medications with your eye care provider and your prescribing physician before your procedure
- Eat a normal meal before your appointment unless instructed otherwise
- Wear comfortable clothing and leave valuables at home
Anti-VEGF injections are performed in the office setting and take only a few minutes. The eye is numbed with anesthetic drops, and the surface is cleaned with an antiseptic solution. The injection itself is delivered through a very thin needle and lasts only seconds. Most patients report feeling a sense of pressure rather than sharp pain. After the injection, you may notice floaters or a mild sensation of fullness in the eye, which typically resolves within a day or two.
Panretinal photocoagulation laser treatment is also performed in the office. A special contact lens is placed on the eye to focus the laser beam, and the treatment is delivered through a series of brief pulses. Each session typically takes between fifteen and forty-five minutes, depending on how much of the retina needs to be treated. You may feel a mild stinging or aching sensation during the procedure, and your provider can adjust the laser settings to help manage any discomfort.
Recovery following anti-VEGF injections is generally rapid. Most patients can return to their normal activities the day after the procedure. Your eye may feel slightly irritated or scratchy for a day or two, and you may be prescribed antibiotic eye drops to use for a short period following the injection.
After PRP laser treatment, you may experience some blurriness, mild aching, or sensitivity to light for one to two days. Your peripheral vision or night vision may be slightly reduced, and these changes can sometimes be noticeable in your daily activities. Your provider will discuss what degree of change is expected based on the amount of laser treatment performed.
Recovery from vitrectomy surgery is more involved and may take several weeks. You may need to maintain a specific head position for a period of time if a gas bubble was placed in the eye. Activity restrictions, such as avoiding heavy lifting and strenuous exercise, are common during the healing period. Your surgical team will provide a detailed recovery plan and schedule follow-up visits to monitor your progress.
Your Treatment Journey
Managing proliferative diabetic retinopathy is an ongoing process rather than a single event. The treatment timeline varies considerably depending on the severity of the condition, how well you respond to initial treatment, and how your diabetes is managed overall. A typical treatment journey may include the following phases.
- Initial evaluation and diagnostic imaging to assess the extent of disease
- A first course of treatment, which may involve anti-VEGF injections, laser therapy, or both
- Follow-up visits at regular intervals to monitor response, often every four to eight weeks initially
- Additional treatments as needed based on how the abnormal vessels respond
- Transition to a longer-term monitoring schedule once the condition is stabilized
Patients who begin with anti-VEGF injections may require a loading phase of several injections given at monthly intervals, followed by an extended treatment schedule that is adjusted based on disease activity. Some patients eventually achieve stability and can be monitored less frequently, while others require ongoing treatment to maintain control of the disease.
Regular follow-up appointments are essential for managing proliferative diabetic retinopathy effectively. During these visits, your retina specialist will examine the retina, review imaging studies, and determine whether additional treatment is warranted. These appointments allow your care team to detect any recurrence of abnormal vessel growth or new complications before they cause significant damage.
At Washington Eye Institute, we emphasize the importance of keeping all scheduled follow-up appointments, even when your vision feels stable. PDR can progress silently, and changes may be detected on examination or imaging well before you notice any symptoms. Consistent monitoring gives your treatment team the best opportunity to intervene early when needed.
Living with proliferative diabetic retinopathy requires a commitment to both eye care and overall health management. The following strategies are important components of long-term disease management.
- Working closely with your endocrinologist or primary care physician to optimize blood sugar control
- Maintaining healthy blood pressure and cholesterol levels
- Attending all scheduled eye examinations and treatment appointments
- Reporting any new visual symptoms to your eye care provider without delay
- Following a balanced diet and engaging in regular physical activity as advised by your medical team
- Avoiding tobacco use, which contributes to blood vessel damage
With appropriate treatment and diligent follow-up care, many patients with proliferative diabetic retinopathy are able to maintain useful vision for years. The key is early detection, timely treatment, and a sustained commitment to managing both the eye condition and the underlying diabetes.
Questions and Answers About Proliferative Diabetic Retinopathy
Proliferative diabetic retinopathy is distinguished from earlier stages by the growth of new, abnormal blood vessels on the retina and optic nerve. In non-proliferative diabetic retinopathy, damage is limited to the existing blood vessels, which may leak or become blocked. The transition to PDR occurs when oxygen deprivation in the retina triggers neovascularization. These fragile new vessels create the risk of vitreous hemorrhage, where blood leaks into the gel-filled center of the eye, and tractional retinal detachment, where scar tissue pulls the retina away from its normal position. Both complications can cause sudden and significant vision loss.
The number of treatments required varies from patient to patient and depends on the severity of the disease and how it responds to therapy. Some patients achieve good control with a series of anti-VEGF injections combined with one or two sessions of panretinal photocoagulation laser treatment. Others may require ongoing anti-VEGF injections over a period of months or years to keep abnormal vessel growth in check. In more complex cases involving vitreous hemorrhage or retinal detachment, vitrectomy surgery may be necessary. Your retina specialist will reassess your condition at each follow-up visit and adjust the treatment plan accordingly.
The primary goal of PDR treatment is to prevent further vision loss and stabilize the condition. In some cases, patients do experience improvement in their vision following treatment, particularly if swelling in the retina resolves or if blood from a vitreous hemorrhage clears after surgery. However, vision that has been lost due to retinal damage from prolonged oxygen deprivation or retinal detachment may not be fully recoverable. This is why early detection and treatment are so important. The sooner abnormal vessel growth is identified and addressed, the better the chances of preserving functional vision for the long term.
Without treatment, proliferative diabetic retinopathy tends to progress and can lead to serious, vision-threatening complications. The abnormal blood vessels continue to grow and are prone to bleeding into the vitreous cavity, causing sudden visual obstruction. Over time, scar tissue associated with these vessels can contract and pull the retina away from the underlying tissue, resulting in tractional retinal detachment. If the detachment involves the macula, which is the central part of the retina responsible for detailed vision, the consequences for sight can be severe. Seeking treatment at the appropriate time is one of the most important steps you can take to protect your vision.
Maintaining well-controlled blood sugar levels plays a significant role in the success of PDR treatment and in slowing the overall progression of diabetic eye disease. Elevated blood sugar damages blood vessels throughout the body, including those in the retina, and can counteract the benefits of eye-specific treatments like anti-VEGF injections and laser therapy. Patients who work with their medical team to keep their hemoglobin A1c within the recommended range tend to respond more favorably to treatment and may require fewer interventions over time. Managing diabetes effectively is a partnership between you, your primary care provider or endocrinologist, and your eye care team at Washington Eye Institute.
Comprehensive dilated eye exams are the single most important tool for detecting and monitoring proliferative diabetic retinopathy. Because PDR can progress without noticeable symptoms, regular examinations allow your eye care provider to identify changes in the retina before they lead to complications. During these exams, your provider uses specialized imaging technology to evaluate the health of your retinal blood vessels and detect any new areas of abnormal vessel growth. For patients who have already been diagnosed with PDR, follow-up exams are essential for assessing how well treatment is working and for making timely adjustments to the care plan. Staying consistent with your exam schedule is one of the most effective ways to safeguard your vision over the long term.